Levocetirizine Does Not Cause Clinically Significant Anticholinergic Effects
Levocetirizine, as a second-generation antihistamine, has little to no anticholinergic activity and is not associated with the anticholinergic side effects (dry mouth, dry eyes, constipation, urinary retention, narrow-angle glaucoma risk) that characterize first-generation antihistamines 1.
Evidence from Guidelines
The most authoritative evidence comes from the 2008 rhinitis practice parameter published in the Journal of Allergy and Clinical Immunology, which explicitly states that "second-generation antihistamines have been associated with less or no tendency for impairment of performance, drowsiness, or anticholinergic effects" 1. This guideline clearly distinguishes second-generation agents (including levocetirizine) from first-generation antihistamines, which commonly cause anticholinergic effects such as:
- Dryness of mouth and eyes
- Constipation
- Inhibition of micturition (urinary retention)
- Increased risk for narrow-angle glaucoma provocation
Research Evidence Confirms Minimal Anticholinergic Activity
A 2005 functional study directly tested the anticholinergic properties of multiple antihistamines using two bioassays 2. Cetirizine (the racemic mixture containing levocetirizine) showed no anticholinergic activity in either in vitro or in vivo models, even at high concentrations up to 3 × 10⁻⁴ M. In contrast, first-generation antihistamines like cyproheptadine, promethazine, and diphenhydramine demonstrated significant anticholinergic potency.
Clinical Implications
What This Means for Practice:
- Levocetirizine can be safely used in patients where anticholinergic effects would be problematic, including:
- Elderly patients with benign prostatic hypertrophy
- Patients with narrow-angle glaucoma or elevated intraocular pressure
- Patients with cognitive impairment
- Those with constipation or urinary retention issues
Important Caveat About Sedation:
While levocetirizine lacks anticholinergic effects, it can cause modest sedative effects (risk ratio 1.67 compared to placebo) 3. This sedation is not due to anticholinergic mechanisms but rather to some degree of central nervous system penetration. However, this sedative effect is significantly less than first-generation antihistamines and comparable to other second-generation agents.
When Anticholinergic Effects Are Actually Desired:
The guidelines note that anticholinergic properties may occasionally be beneficial (e.g., persistent rhinorrhea despite second-generation antihistamines and intranasal corticosteroids) 1. In such cases, a topical anticholinergic agent (like ipratropium nasal spray) is preferred over switching to a first-generation antihistamine with systemic anticholinergic effects.
Bottom Line
Levocetirizine is appropriately classified as having minimal to no anticholinergic activity, making it a safe choice when anticholinergic side effects need to be avoided. The drug's side effect profile is primarily limited to potential mild sedation, not anticholinergic effects 1, 2.